186 related articles for article (PubMed ID: 16145759)
1. Concerns about COX-2 painkillers. They're easier on the stomach, potentially harder on your heart.
Heart Advis; 2002 Jan; 5(1):2. PubMed ID: 16145759
[No Abstract] [Full Text] [Related]
2. Summaries for patients. Cyclooxygenase-2 inhibitors and heart attacks: varying effects?
Ann Intern Med; 2005 Feb; 142(3):I21. PubMed ID: 15684199
[No Abstract] [Full Text] [Related]
3. COX-2 selective inhibitors--important lessons learned.
Maxwell SR; Webb DJ
Lancet; 2005 Feb 5-11; 365(9458):449-51. PubMed ID: 15705439
[No Abstract] [Full Text] [Related]
4. Arthritis. Should you be taking a COX-2 inhibitor?
Harv Health Lett; 2001 Nov; 27(1):1-3. PubMed ID: 11724695
[No Abstract] [Full Text] [Related]
5. Celecoxib shown effective in preventing colon polyps.
Nelson NJ
J Natl Cancer Inst; 2006 May; 98(10):665-7. PubMed ID: 16705118
[No Abstract] [Full Text] [Related]
6. Painful lessons.
Nat Struct Mol Biol; 2005 Mar; 12(3):205. PubMed ID: 15744317
[No Abstract] [Full Text] [Related]
7. The Vioxx debacle revisited.
Abeles M; Abeles AM
Am J Med; 2005 Sep; 118(9):1057-8. PubMed ID: 16164907
[No Abstract] [Full Text] [Related]
8. Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction.
Kimmel SE; Berlin JA; Reilly M; Jaskowiak J; Kishel L; Chittams J; Strom BL
Ann Intern Med; 2005 Feb; 142(3):157-64. PubMed ID: 15684203
[TBL] [Abstract][Full Text] [Related]
9. [Pseudoporphyria and coxib].
Schmutz JL; Barbaud A; Trechot P
Ann Dermatol Venereol; 2006 Feb; 133(2):213. PubMed ID: 16508618
[No Abstract] [Full Text] [Related]
10. COX-2 inhibitors and cardiovascular toxicity: a class effect?
Laible B
S D J Med; 2005 Mar; 58(3):93-4. PubMed ID: 15794479
[No Abstract] [Full Text] [Related]
11. Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study.
Johnsen SP; Larsson H; Tarone RE; McLaughlin JK; Nørgård B; Friis S; Sørensen HT
Arch Intern Med; 2005 May; 165(9):978-84. PubMed ID: 15883235
[TBL] [Abstract][Full Text] [Related]
12. COX-2 inhibitors--a lesson in unexpected problems.
Drazen JM
N Engl J Med; 2005 Mar; 352(11):1131-2. PubMed ID: 15713947
[No Abstract] [Full Text] [Related]
13. Cardiovascular events and COX-2 inhibitors.
Fleming M
JAMA; 2001 Dec; 286(22):2808; author reply 2811-2. PubMed ID: 11735742
[No Abstract] [Full Text] [Related]
14. Cyclooxygenase-2 inhibitors and cardiovascular risk.
Smith ER
Can J Cardiol; 2005 Mar; 21(3):307-8. PubMed ID: 15776124
[No Abstract] [Full Text] [Related]
15. [COX-2 inhibitors--one step forward and two steps back].
Evensen S; Spigset O; Slørdal L
Tidsskr Nor Laegeforen; 2005 Apr; 125(7):875-8. PubMed ID: 15815733
[TBL] [Abstract][Full Text] [Related]
16. A side effect of COX-2 inhibitors.
Harv Health Lett; 2003 Apr; 28(6):7. PubMed ID: 12777233
[No Abstract] [Full Text] [Related]
17. Celecoxib- and rofecoxib-induced delirium.
Macknight C; Rojas-Fernandez CH
J Neuropsychiatry Clin Neurosci; 2001; 13(2):305-6. PubMed ID: 11449042
[No Abstract] [Full Text] [Related]
18. Tailoring arthritis therapy in the wake of the NSAID crisis.
Olsen NJ
N Engl J Med; 2005 Jun; 352(25):2578-80. PubMed ID: 15972863
[No Abstract] [Full Text] [Related]
19. Cyclooxygenase inhibition and adverse remodeling during healing after myocardial infarction.
Jugdutt BI
Circulation; 2007 Jan; 115(3):288-91. PubMed ID: 17242292
[No Abstract] [Full Text] [Related]
20. What's all the fuss? Safety concerns about COX-2 inhibitors rofecoxib (Vioxx) and celecoxib (Celebrex).
Wooltorton E
CMAJ; 2002 Jun; 166(13):1692-3. PubMed ID: 12126328
[No Abstract] [Full Text] [Related]
[Next] [New Search]
